These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 28147335)
21. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer. Yang GS; Wang Y; Wang P; Chen ZD Chin Med J (Engl); 2007 Sep; 120(18):1611-5. PubMed ID: 17908481 [TBL] [Abstract][Full Text] [Related]
22. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912 [TBL] [Abstract][Full Text] [Related]
23. Correlation of serum free prostate-specific antigen level with histological findings in patients with prostatic disease. Lakhey M; Ghimire R; Shrestha R; Bhatta AD Kathmandu Univ Med J (KUMJ); 2010; 8(30):158-63. PubMed ID: 21209527 [TBL] [Abstract][Full Text] [Related]
24. Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study. Wang L; Zhang P; Meng X; Chen X; Xiang Z; Lin X; Liu Y; Gan W; Han X; Li D Fam Cancer; 2016 Apr; 15(2):309-15. PubMed ID: 26547439 [TBL] [Abstract][Full Text] [Related]
25. Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigen. Morote J; Raventós CX; Encabo G; López M; de Torres IM Eur Urol; 2000 Apr; 37(4):456-9. PubMed ID: 10765077 [TBL] [Abstract][Full Text] [Related]
26. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients. Henrique R; Ribeiro FR; Fonseca D; Hoque MO; Carvalho AL; Costa VL; Pinto M; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C Clin Cancer Res; 2007 Oct; 13(20):6122-9. PubMed ID: 17947477 [TBL] [Abstract][Full Text] [Related]
27. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies. Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the clinical value of the newly identified urine biomarker HIST1H4K for diagnosis and prognosis of prostate cancer in Bulgarian patients. Kachakova D; Mitkova A; Popov E; Beltcheva O; Vlahova A; Dikov T; Hristova S; Mitev V; Slavov C; Kaneva R J BUON; 2013; 18(3):660-8. PubMed ID: 24065480 [TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer. Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690 [TBL] [Abstract][Full Text] [Related]
31. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401 [TBL] [Abstract][Full Text] [Related]
32. Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer. Qu LG; Wardan H; Davis ID; Iddawela M; Sluka P; Pezaro CJ BJU Int; 2019 Nov; 124 Suppl 1():50-56. PubMed ID: 31090242 [TBL] [Abstract][Full Text] [Related]
33. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Rouprêt M; Hupertan V; Yates DR; Catto JW; Rehman I; Meuth M; Ricci S; Lacave R; Cancel-Tassin G; de la Taille A; Rozet F; Cathelineau X; Vallancien G; Hamdy FC; Cussenot O Clin Cancer Res; 2007 Mar; 13(6):1720-5. PubMed ID: 17363525 [TBL] [Abstract][Full Text] [Related]
34. Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostatic specific antigen. Morote J; Encabo G; Lopez M; de Torres IM BJU Int; 1999 Oct; 84(6):657-60. PubMed ID: 10510111 [TBL] [Abstract][Full Text] [Related]
35. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue. Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301 [TBL] [Abstract][Full Text] [Related]
36. A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA. Brikun I; Nusskern D; Decatus A; Harvey E; Li L; Freije D Clin Epigenetics; 2018; 10():91. PubMed ID: 29988684 [TBL] [Abstract][Full Text] [Related]
37. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels. Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873 [TBL] [Abstract][Full Text] [Related]
38. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race. Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929 [TBL] [Abstract][Full Text] [Related]
39. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis. Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830 [TBL] [Abstract][Full Text] [Related]
40. Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm. Cho NY; Kim JH; Moon KC; Kang GH Virchows Arch; 2009 Jan; 454(1):17-23. PubMed ID: 19048291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]